Certainly! Here is the content you requested:
Ultrasound-Guided Breast Cancer Cryoablation – PubMed
OBJECTIVE: Percutaneous ultrasound-guided breast cryoablation is a minimally invasive technique that kills targeted tissue with extreme cold, requires only local anesthesia, and takes less than 45 minutes too complete.
CONCLUSION: We discuss the indications for breast cryoablation, the …
Read more
Breast Cryoablation: Techniques, Indications, and Challenges
Ultrasound-guided cryoablation for mass in the right breast at 10 o’clock. The cryoprobe is inserted through the center of the mass on ultrasound, extending past the margin of the mass. e, f Images demonstrate the ice ball in long and short axis which should be twice the size of the mass by the second freeze cycle. Pathology demonstrated …
Read more
Ultrasound-Guided Cryoablation: Minimally Invasive breast Cancer Treatment
Breast cancer treatment has advanced considerably over the years, with various methods being employed to improve patient outcomes. One such innovative method is ultrasound-guided cryoablation, which offers a safe, effective, and minimally invasive outpatient procedure …
[Read more](https://healthmanagement.org/pdf/article/ultrasound-guided-cryoablat…se trends over a range of pathologic breast cancer subtypes and sizes.
The study included 60 women who were treated via ultrasound-guided cryoablation between 2018 and 2023. Of the total women, 45 had invasive ductal carcinoma, six had invasive lobular carcinoma, two had multicentric ductal carcinoma in situ (DCIS), and seven had other histology. Tumor size ranged from 0.3 cm to 9 cm, with an average of 2.7 cm.
Compared with women with no recurrence, women in the recurrence group had more poorly differentiated disease (66.7% vs. 22.2%, p = 0.038). Tumor size did not differ between nonrecurrence and recurrence groups. While the nonrecurrence group had an average of 2.7 cm,the recurrence group had an average of 2.5 cm (p = 0.506).
The researchers also observed a important age difference between women who were treated with palliative intent (79.7 years) rather than curative intent (72.5 years, p = 0.032).
four women experienced skin injuries with blistering due to the ice ball formed through the procedure. The researchers noted that all recovered within one to two weeks through conservative management using silver sulfadiazine.
With these results in mind, the study authors highlighted cryoablation as a “promising” treatment option for these women.
The study can be accessed in its entirety here.
